BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
Jersey Desk/10079471

FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC).stats

More on Jersey Desk
Filed Under: Business

Show All News | Report Violation

0 Comments

Latest on Jersey Desk